Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Response to 1st-line Treatment with BR or R-CHOP in Patients with Indolent non-Hodgkin’s Lymphoma: First Outcome Data from the German Prospective TLN Registry.

Knauf, W.U., Abenhardt, W., Hansen, R., Grugel, R., Harde, J., Marschner, N., 2013.

Blood 122(21), 3036.

Abstract

Download

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
TLN
2013
Response to 1st-line Treatment with BR or FCR in Patients with Chronic Lymphocytic Leukaemia: First Outcome Data from the German Prospective TLN Registry.

Knauf, W.U., Abenhardt, W., Engel, E., Grugel, R., Harde, J., Marschner, N., 2013.

Blood 122(21), 4181.

Abstract

Download

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
TLN
2013
Therapy of relapsed/ refractory multiple myeloma with a combination of Lenalidomide plus Dexamethasone: First interim analysis of the non-interventional study “Revlimid.”

Knauf, W., Aldaoud, A., Groschek, M., Teichmann, B., Harde, J., Hasskarl, J., 2013.

Onkologie 36 (suppl. 7)(P532), 155. doi:10.1159/000356365

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: DGHO / Journal: Onkologie
Revlimid-NIS
2013
Treatment of indolent NHL by office-based haematologists in Germany: R-bendmustine replaces R-CHOP as “Standard of Care.”

Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2013.

Hematol Oncol 31 (Suppl. I)(Abstract 467), 248. doi:10.1002/hon.2059

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ICML / Journal: Hematological Oncology
TLN
2013
Treatment of Elderly Patients with CLL: Does Bendamustine Replace Chlorambucil as “Standard of Care”?

Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2013.

Hematol Oncol 31 (Suppl. I)(Abstract 372), 219. doi:10.1002/hon.2059

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ICML / Journal: Hematological Oncology
TLN
2013
VMP in 1st-Line Treatment of Non-Transplant Patients with Multiple Myeloma in Routine Practice: First Follow-Up Data from the Tumour Registry Lymphatic Neoplasms.

Knauf, W., Abenhardt, W., Harich, H.-D., Schlag, R., Grugel, R., Marschner, N., 2013.

Onkologie 36 (suppl 7)(P528), 152–153. doi:10.1159/000356365

Abstract

Download

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: DGHO / Journal: Onkologie
TLN
2013
A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial of immunotherapy with L-BLP25 (tecemotide) in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy.

Kasper, S., Overkamp, F., Moehler, M., Kullmann, F., Lang, H., Schoen, M., Smith-Machnow, V., Hegewisch-Becker, S., Seehofer, D., Bechstein, W., Heike, M., Voehringer, M., Heinemann, V., Greil, R., Geissler, M., Lordick, F., Peeters, M., Van Cutsem, E., Galle, P.R., Schimanski, C.C., 2013.

J Clin Oncol 31(suppl; abstr TPS3124). doi: 10.1200/jco.2013.31.15_suppl.tps3124

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: ASCO / Journal: Journal of Clinical Oncology
LICC
2013
Prediction of second-line therapy response in metastatic renal cell carcinoma patients by blood plasma marker proteins.

Hölters, S., Bergmann, L., Grünwald, V., Keilholz, U., Ohlmann, C., Staehler, M., Schmerler, D., Junker, K., 2013.

Meeting of the EAU Section of Urological Research P17.

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: ESUR (EAU) / Journal: -
MARC-2
2013
Bone metastasis in solid tumors in German outpatient centers – data from clinical registries.

Hartmann, H., Fietz, T., Köhler, A., Marschner, N., 2013.

Onkologie 36 (suppl. 7)(P842), 258. doi:10.1159/000356365

Abstract

Download

Indikation: Other, Sonstige / Veranstaltung: DGHO / Journal: Onkologie
Registerübergreifend
2013
Efficacy of trastuzumab re-therapy in routine treatment of HER2-positive breast cancer patients who relapsed after completed (neo-)adjuvant anti-HER2 therapy.

Hanker, L., Hitschold, T., Hesse, T., Grafe, A., Förster, F., Schröder, J., Janssen, J., Reichert, D., Hielscher, C., Greinemann, J., Bórquez, D., Schmidt, M., 2013.

J Clin Oncol 31(suppl; abstr 602). doi:DOI: 10.1200/jco.2013.31.15_suppl.602

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ASCO / Journal: Journal of Clinical Oncology
Herceptin-NIS
2013